NCT03270579View on ClinicalTrials.gov

A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-64511070

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

September 12, 2017

Primary Completion Date

February 6, 2018

Study Completion Date

February 6, 2018

Conditions
Healthy
Interventions
DRUG

[18F]JNJ-64511070

An IV injection of 185 MBq \[18F\]JNJ-64511070 will be administered.

Trial Locations (1)

3000

UZ Leuven Gasthuisberg, Leuven

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT03270579 - A Study to Investigate the Regional Brain Kinetics of the Positron Emission Tomography Ligand [18F]JNJ-64511070 | Biotech Hunter | Biotech Hunter